ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,35
-0,04%
Bitcoin
60 974,30
-0,77%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Eagle Capital Growth Fund Inc (GRF)

  7. Eagle Capital Growth Fund Inc (GRF) Actualités

GRF

Eagle Capital Growth (GRF)

Eagle Capital Growth Fund Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:GRF
DateHeureSourceTitreSymboleSociété
18/04/202415h30GlobeNewswire Inc.Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C.AMEX:GRFEagle Capital Growth Fund Inc
04/04/202410h00GlobeNewswire Inc.Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus ScreeningAMEX:GRFEagle Capital Growth Fund Inc
07/03/202417h11Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:GRFEagle Capital Growth Fund Inc
06/03/202418h56Edgar (US Regulatory)Form N-CSR - Certified Shareholder ReportAMEX:GRFEagle Capital Growth Fund Inc
28/02/202417h20Edgar (US Regulatory)Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public)AMEX:GRFEagle Capital Growth Fund Inc
23/02/202422h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
14/02/202409h16GlobeNewswire Inc.Grifols announces positive topline phase 3 fibrinogen clinical trial resultsAMEX:GRFEagle Capital Growth Fund Inc
13/02/202421h09Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesAMEX:GRFEagle Capital Growth Fund Inc
27/12/202321h58Edgar (US Regulatory)Form 40-17G - Fidelity Bond [Rule 17G-1(g)]AMEX:GRFEagle Capital Growth Fund Inc
15/11/202314h00GlobeNewswire Inc.Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous Dosing Option for Patients with Alpha1-Antitrypsin DeficiencyAMEX:GRFEagle Capital Growth Fund Inc
06/11/202314h00GlobeNewswire Inc.GigaGen Presents IND-Enabling Data and Phase 1 Trial Strategy for its Novel Anti-CTLA-4 Oncology Drug Candidate, GIGA-564, at SITC 2023AMEX:GRFEagle Capital Growth Fund Inc
25/10/202300h30GlobeNewswire Inc.Araclon Biotech Presents Positive Final Results from Phase 2 Clinical Study of ABvac40 Alzheimer’s Vaccine at CTADAMEX:GRFEagle Capital Growth Fund Inc
13/10/202323h30Business WireEagle Capital Growth Fund Declares Year-End Distribution of $0.35 Per Share in CashAMEX:GRFEagle Capital Growth Fund Inc
02/10/202320h30Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipAMEX:GRFEagle Capital Growth Fund Inc
02/10/202320h16Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]AMEX:GRFEagle Capital Growth Fund Inc
15/08/202321h45Edgar (US Regulatory)Form N-CSRS - Certified Shareholder Report, Semi-AnnualAMEX:GRFEagle Capital Growth Fund Inc
01/08/202314h00GlobeNewswire Inc.Grifols Accelerates Healthcare Innovation with Google Cloud’s AI and AnalyticsAMEX:GRFEagle Capital Growth Fund Inc
12/05/202319h28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)AMEX:GRFEagle Capital Growth Fund Inc
12/05/202318h43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:GRFEagle Capital Growth Fund Inc
19/04/202321h25Edgar (US Regulatory)Monthly Portfolio Investments Report on Form N-port (public) (nport-p)AMEX:GRFEagle Capital Growth Fund Inc
18/04/202316h30PR Newswire (US)Grifols 2022 Annual Report on Form 20-F filed with the SEC on April 18, 2023AMEX:GRFEagle Capital Growth Fund Inc
17/03/202314h40Edgar (US Regulatory)Certified Annual Shareholder Report for Management Investment Companies (n-csr)AMEX:GRFEagle Capital Growth Fund Inc
01/03/202312h42Edgar (US Regulatory)Annual Report for Registered Investment Companies (n-cen)AMEX:GRFEagle Capital Growth Fund Inc
14/02/202318h38Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)AMEX:GRFEagle Capital Growth Fund Inc
27/12/202220h03Edgar (US Regulatory)Fidelity Bond Filed Pursuant to Rule 17g-1(g)(1) of the Investment Company Act of 1940 (40-17g)AMEX:GRFEagle Capital Growth Fund Inc
14/10/202223h00Business WireEagle Capital Growth Fund Declares Year-End Distribution of $0.37 Per Share in CashAMEX:GRFEagle Capital Growth Fund Inc
23/08/202220h02Edgar (US Regulatory)Certified Semi-annual Shareholder Report for Management Investment Companies (n-csrs)AMEX:GRFEagle Capital Growth Fund Inc
12/05/202215h53GlobeNewswire Inc.Deutsche Bank’s Depositary Receipts Virtual Investor Conference presentations now available for on-demand viewingAMEX:GRFEagle Capital Growth Fund Inc
05/05/202214h58GlobeNewswire Inc.International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on May 10th and 11th, 2022AMEX:GRFEagle Capital Growth Fund Inc
01/04/202219h37Edgar (US Regulatory)Amended Certified Annual Shareholder Report for Management Investment Companies (n-csr/a)AMEX:GRFEagle Capital Growth Fund Inc
 Showing the most relevant articles for your search:AMEX:GRF

Dernières Valeurs Consultées

COIN
WHENGBP
LSE
KYGA
Kerry
USOTC
EBCRY
Embracer Group AB (PK)
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés